Plus Therapeutics Inc (fka Cytori Therapeutics) is a specialty therapeutics company focused on cancer care. It provides nanotechnology platform for reformulating several hydrophilic and lipophilic Active Pharmaceutical Ingredients. The product candidates of the company include Patented DocePlus and Generic Doxo plus.
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.